Tetrahydrocurcumin compositions, methods of making, and methods of using the same
US-12115138-B2 · Oct 15, 2024 · US
Methods of treating prader-willi syndrome
US2016346232A1 · US · A1
| Field | Value |
|---|---|
| Publication number | US-2016346232-A1 |
| Application number | US-201615155625-A |
| Country | US |
| Kind code | A1 |
| Filing date | May 16, 2016 |
| Priority date | Apr 30, 2015 |
| Publication date | Dec 1, 2016 |
| Grant date | — |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
Methods of treating Prader-Willi syndrome in a subject in need of treatment are provided. The methods include administering to the subject an effective amount of a compound of Formula I, or a pharmaceutically acceptable salt thereof, wherein R, R′, X, Y and Z are defined as set forth in the specification. In embodiments, an effective amount of captodiamine or a pharmaceutically acceptable salt thereof is administered to the subject.
First claim
Opening claim text (preview).
What is claimed is: 1 . A method of treating Prader-Willi syndrome comprising administering to a subject with Prader-Willi syndrome a pharmaceutical composition comprising an effective amount of a compound according to Formula I wherein X is an ethylene, propylene, butylene or pentylene group; R is C 1-9 alkyl, preferably C 1-5 alkyl; R′ is C 1-9 alkyl, alkenyl or alkynyl;…
Assignees
Inventors
Classifications
- A61K31/145Primary
Human Necessities · mapped topic
Patent family
Related publications grouped by family.
External sources
Next steps
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US2016346232A1 cover?
- Methods of treating Prader-Willi syndrome in a subject in need of treatment are provided. The methods include administering to the subject an effective amount of a compound of Formula I, or a pharmaceutically acceptable salt thereof, wherein R, R′, X, Y and Z are defined as set forth in the specification…
- Who is the assignee on this patent?
- Ovid Therapeutics Inc
- What technology area does this patent fall under?
- Primary CPC classification A61K31/145. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Thu Dec 01 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).